Pending further research, colorimetric capnography looks promising.
Options for confirming naso-orogastric (NG) tube placement include chest radiography (the traditional standard), litmus or pH paper, ultrasound imaging, bulb syringe aspiration, and capnography. Investigators evaluated a self-inflating bulb syringe and a colorimetric CO2 indicator in 202 critically ill patients, 60% of whom were mechanically ventilated.
The NG tube was inserted to a depth of 30 cm, then an attempt was made to aspirate air with a self-inflating bulb syringe; if the syringe did not inflate within 5 seconds, the tube was deemed to be in the esophagus. A colorimetric CO2 indicator was then attached to the NG tube and the result was recorded (presumably external ventilation was provided); absence of color change indicated esophag…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals